{"version":"1.0","provider_name":"Bioceltix","provider_url":"https:\/\/bioceltix.com\/en\/","title":"Stock Market Information - Bioceltix","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"doeL1Vp4Z8\"><a href=\"https:\/\/bioceltix.com\/en\/investor-relations\/stock-market-information\/\">Stock Market Information<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/bioceltix.com\/en\/investor-relations\/stock-market-information\/embed\/#?secret=doeL1Vp4Z8\" width=\"600\" height=\"338\" title=\"&#8220;Stock Market Information&#8221; &#8212; Bioceltix\" data-secret=\"doeL1Vp4Z8\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/bioceltix.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Stock Market Information Go back to Investor Relations Important financial data Financial statements Information Important financial data \u00a0 Particulars 31.12.2025 31.12.2024 in PLN in EUR in PLN in EUR 1. Net revenues from product sales 0,00 0,00 0,00 0,00 2. Operating profit (loss) -15 269 847,55 -3 603 758,98 -15 033 836,30 -3 492 829,40 [&hellip;]"}